A ganglioside in which the oligosaccharide portion is composed of an tetrasaccharide, to which one or more sialic acid residues are attached.
ChEBI ID: 36543
Member | Definition | Role |
---|---|---|
g(m1) ganglioside | A sialotetraosylceramide consisting of a branched pentasaccharide made up from one sialyl residue, two galactose residues, one N-acetylgalactosamine residue and a glucose residue at the reducing end attached to N-stearoylsphingosine via a beta-linkage. | ganglioside GM1 |
siagoside | A sialotetraosylceramide consisting of the disialoganglioside GM1 with a lactone ring formed between C-1 of the NeuNac residue and C-2 of the galactose residue proximal to the ceramide moiety. | 3)-[beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-stearoylsphingosine-1(II'),2(II)-lactone.html>alpha-Neu5Ac-(2->3)-[beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-stearoylsphingosine 1(II'),2(II) lactone |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 1,004 (25.21) | 18.7374 |
1990's | 1,338 (33.59) | 18.2507 |
2000's | 891 (22.37) | 29.6817 |
2010's | 584 (14.66) | 24.3611 |
2020's | 166 (4.17) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 74 (1.79%) | 5.53% |
Reviews | 224 (5.42%) | 6.00% |
Case Studies | 227 (5.49%) | 4.05% |
Observational | 1 (0.02%) | 0.25% |
Other | 3,610 (87.28%) | 84.16% |